Dear group, What is the current consensus regarding flow cytometric analysis of CD52 in CLL's for CAMPATH-1H treatment? Are flow labs performing CD52 staining on all of their CLL's and are most clinicians using this information for treatment decisions? Thank you for your help! Andrea Illingworth, MS, H(ASCP) Dahl-Chase Flow Cytometry 333 State Street Bangor, Maine 04401
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:26:09 EST